Regenxbio (RGNX) Asset Utilization Ratio (2015 - 2025)

Regenxbio's Asset Utilization Ratio history runs 11 years deep, the most recent figure standing at 0.35 for Q4 2025.

• In Q4 2025, Asset Utilization Ratio rose 105.98% year-over-year to 0.35; the TTM figure through Dec 2025 stood at 0.35 (up 105.98% YoY), while the FY2025 annual figure was 0.37, up 131.46% from the prior year.
• Asset Utilization Ratio was 0.35 for Q4 2025 at Regenxbio, up from 0.29 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.52 in Q3 2022 to a low of 0.11 in Q3 2021.
• Historically, Asset Utilization Ratio has averaged 0.25 across 5 years, with a median of 0.18 in 2024.
• Biggest YoY gain for Asset Utilization Ratio was 359.18% in 2022; the steepest drop was 73.28% in 2022.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.49 in 2021, then tumbled by 73.28% to 0.13 in 2022, then grew by 13.81% to 0.15 in 2023, then increased by 13.21% to 0.17 in 2024, then surged by 105.98% to 0.35 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.35 (Q4 2025), 0.29 (Q3 2025), and 0.29 (Q2 2025), per Business Quant data.